-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Neurocrine Biosciences Inc quarterly/annual Costs and Expenses history and growth rate from 2020 to 2024.
- Neurocrine Biosciences Inc Costs and Expenses for the quarter ending December 31, 2024 was $486M, a 33.1% increase year-over-year.
- Neurocrine Biosciences Inc Costs and Expenses for the twelve months ending December 31, 2024 was $1.78B, a 9.08% increase year-over-year.
- Neurocrine Biosciences Inc annual Costs and Expenses for 2024 was $1.78B, a 9.08% increase from 2023.
- Neurocrine Biosciences Inc annual Costs and Expenses for 2023 was $1.64B, a 32% increase from 2022.
- Neurocrine Biosciences Inc annual Costs and Expenses for 2022 was $1.24B, a 20.2% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)